Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
20 studies found for:    "Stuttering"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Suspended A Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Tolerability of Asenapine With Flexible Dosing From 5mg to 20mg in Adults With Developmental Stuttering
Condition: Stuttering
Intervention: Drug: Asenapine
2 Completed A Study to Assess the Efficacy and Safety of Pagoclone for Adults With Stuttering
Condition: Stuttering
Interventions: Drug: pagoclone;   Other: placebo
3 Recruiting Genetic Linkage Studies of Stuttering
Condition: Stuttering
Intervention:
4 Withdrawn The Effects of Tactile Speech Feedback on Stuttering Frequency
Condition: Stuttering
Intervention: Device: Tactile Stimulation
5 Unknown  Activity of the Auditory Cortex During Speech Perception and Speech Production in Stuttering
Condition: Stuttering
Intervention:
6 Completed Genetic Factors Related to Stuttering
Condition: Stuttering
Intervention:
7 Unknown  Follow-up of Children After Stuttering Treatment
Condition: Stuttering
Intervention: Behavioral: SMS (Short Message Service) reminders
8 Completed Dopamine Function in Developmental Stuttering
Condition: Developmental Stuttering
Intervention:
9 Completed Safety and Efficacy Study of the Investigational Drug Pagoclone, in the Treatment of Persistent Developmental Stuttering (PDS)
Condition: Persistent Developmental Stuttering
Intervention: Drug: Pagoclone
10 Completed EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study
Condition: Persistent Developmental Stuttering
Interventions: Drug: Pagoclone;   Drug: Placebo
11 Completed Stuttering and Apraxia of Speech: the Efficacy of an Intervention Program
Conditions: Stuttering;   Developmental Apraxia of Speech
Intervention: Behavioral: speech therapy with the assistance of an acoustical analysis program
12 Completed Pilot: Group Therapy for Children Who Stammer
Condition: Stammering
Intervention: Behavioral: One-week speech therapy group
13 Active, not recruiting Enhancing Speech Fluency With Non-invasive Brain Stimulation in Developmental Stuttering
Conditions: Stuttering;   Fluency Disorders;   Speech Disorders
Interventions: Device: Anodal TDCS;   Behavioral: Fluency Training
14 Not yet recruiting Dietary Factors and Disfluency: A Look Into Food Allergies and Other Environmental Triggers Associated With Variations in Severity of Persistent Developmental Stuttering
Conditions: Stuttering;   Speech Disorders;   Fluency Disorders;   Stammering
Intervention: Other: Food Allergy Testing and Elimination Diet
15 Unknown  Spacing Lidcombe Program Clinic Visits
Condition: Stuttering
Intervention: Behavioral: The Lidcombe Program for early stuttering
16 Recruiting Efficacy and Tolerability of Ecopipam in Adults With Childhood Onset Fluency Disorder (Stuttering).
Conditions: Stuttering, Adult;   Childhood-onset Fluency Disorder;   Speech Disorders;   Language Disorders;   Communication Disorder
Interventions: Drug: Ecopipam 50mg;   Drug: Ecopipam 100mg
17 Completed Study of Brain Activity During Speech Production and Speech Perception
Conditions: Developmental Articulation Disorder;   Stuttering
Intervention:
18 Completed Characteristics of Idiopathic Familial Speech Disorders
Conditions: Developmental Articulation Disorder;   Speech Disorder;   Stuttering
Intervention:
19 Terminated Central Mechanisms in Speech Motor Control Studied With H215O PET
Conditions: Communication Disorder;   Healthy;   Stuttering;   Tourette Syndrome;   Voice Disorder
Intervention:
20 Recruiting Botulinum Toxin for the Treatment of Involuntary Movement Disorders
Conditions: Chorea;   Drug Induced Dyskinesia;   Movement Disorder;   Muscular Disease;   Tic Disorder
Intervention: Other: Botulinum Toxin

Study has passed its completion date and status has not been verified in more than two years.